Table 1.
Descriptions of Patients With Stroke Related to MP.
| References | Age & sex | Presenting symptoms | Onset of stroke (days) | Modality of MP diag. | CSF analysis | Abnormal laboratory findings (coagulation profile and antibodies) |
|---|---|---|---|---|---|---|
| Dowd et al. 14 | 31/F | PNA | 21 | NA | NA | Cold agglutinin |
| Mulder et al. 15 | 30 /F | PNA | 7 | CF | Normal | ↑fibrinogen, ↑FDP |
| Socan et al. 16 | 28/F | Cough | 6 | I | Normal, culture (+), PCR (+ | Normal |
| Padovan et al. 17 | 36/F | URTI | 8 | CAA | Normal, serology (+) and PCR (+) | Positive IgM aCL,↑aPTT, positive lupus anticoagulant, ↑D-dimer |
| Idbaih et al. 18 | 35/F | PNA | 21 | NA | NA | NA |
| Siclari et al. 19 | 40/F | PNA | 7 | CAA | NA | Normal |
| Senda et al. 20 | 21/M | URTI | 7 | CAA | Normal | IgM (+) of aCL, ↑PT, ↑APPT, ↑fibrinogen, ↑D-dimer, ↑thrombin-antithrombin III-complex, ↓protein C |
| Benghanem et al 21 | 57/F | PNA | 14 | E | NA | Positive aCL and anti beta2 GP1 Ab; Hemolytic anemia |
| Sarathchandran et al 22 | 39/M | Fever and headache | NA | 58 leucocytes/μL, culture (−) | NA |
Abbreviations: MP, Mycoplasma pneumonia; CSF, cerebrospinal fluid; PNA, pneumonia; NA, not available; CF, complement fixation; FDP, fibrin degradation product; PCR, polymerase chain reaction; URTI, upper respiratory tract infection; CAA, cold agglutinin assay; aCL, anticardiolipin antibody; Ab, antibody.